Antihistamines Market 2018-2026 | Size, Share and Forecast | Credence Research

The global antihistamines market will grow at a CAGR of 8.7% from 2018 to 2026.

SANJOSE, United States – March 27, 2019 /MarketersMedia/ —

According to the latest report published by Credence Research, Inc. “Antihistamines Market – Growth, Future Prospects and Competitive Analysis, 2018 – 2026,” the global antihistamines market will grow at a CAGR of 8.7 percent from 2018 to 2026.

By Antihistamines Type: First Generation Antihistamines, Second Generation Antihistamines
By Application: Allergic Rhinitis, Conjunctivitis, Urticaria, Atopic Dermatitis, Anaphylaxis, Others

Market Insights
The global antihistamines market is expected to grow from 2018 to 2026 at a CAGR of 8.7 percent over the forecast period. Histamine is a key intermediary for instant hypersensitivity reactions that act locally and assist with vasodilatation, smooth muscle contraction, high vascular permeability, inflammation, and edema. Antihistamines are representative of a class of drugs that inhibit the receptors of histamine type 1 (H1). H1 receptor is present on smooth bronchial muscle, gastrointestinal tract, uterus, and large blood vessels. The major application of antihistamines has been observed in the treatment of symptoms such as allergic conditions including itching, runny nose, nasal stuffiness, hives, teary eyes, dizziness, cough, and nausea. Sedation, impaired motor function, dry mouth & throat, dizziness, blurred vision, constipation, and urinary retention are some common side effects observed due to antihistamines treatment. However, modern drug development technologies have helped to reduce the aforementioned side effects of antihistamines since a few decades.

Browse the full report Antihistamines Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/antihistamines-market

The two classes of antihistamines are antihistamines of the first generation and second generation. First-generation antihistamines include drugs such as alimemazine, clemastine, chlorphenamine, hydroxyzine, cyproheptadine, ketotifen, promethazine, and others. Drugs like cetirizine, acrivastine, desloratadine, levocetirizine, fexofenadine, and loratadine. In 2017, the segment of second-generation antihistamines was observed as the largest market as they are used as the first line of action in diseases such as urticaria & common cold, and modern drug development technologies have helped to enhance the activity of second-generation antihistamines e.g.: cetirizine was developed to reduce dizziness caused by cetirizine. Technological support is expected to develop the therapeutic effect of second-generation antihistamines in the near future.

There are several antihistamine applications such as allergic rhinitis, conjunctivitis, urticaria, atopic dermatitis, anaphylaxis, and others (angioedema, pruritus, and others). Allergic rhinitis and urticaria together accounted for more than 50 percent of the market share in 2017 due to the highest global prevalence of disease coupled with increased awareness and accessibility related to disease diagnosis and treatment. According to the American Academy of Allergy Asthma & Immunology (AAAAI), globally allergic rhinitis affects about 10 percent to 30 percent of the population each year. Thus, disease prevalence determines the market demand for antihistamines.

The global antihistamines market experiences huge competition due to the presence of several national and international market players. Since most of the drugs are generic and available over the counter which makes antihistamines market more competitive. Key players in the market include Bayer AG, Almirall S.A., Johnson & Johnson, AstraZeneca plc, Novartis AG, Pfizer, Inc., Sanofi SA, Boehringer Ingelheim GmbH, Merck & Co., Inc., Akorn, Inc., Teva Pharmaceutical Industries Ltd., and others.

Key Market Movements

Globally, the antihistamines market will significantly grow at a CAGR of 8.7% for the period from 2018 to 2026
First generation and second generation antihistamines are further sub-segmented including drugs such as Chlorphenamine, Alimemazine, Clemastine, Hydroxyzine, Cyproheptadine, Ketotifen, Acrivastine, Promethazine, Cetirizine, Fexofenadine, Desloratadine, Loratadine, and Levocetirizine
Second generation antihistamines was identified as the largest market and expected to retain its dominance throughout the forecast period from 2018 to 2026
Asia Pacific was identified as most promising region in the near future during the forecast period 2018 to 2026

Get Sample (Free) @ https://www.credenceresearch.com/sample-request/59231

ToC:
Chapter 1. Preface
…………
Chapter 2. Executive Summary
………….
Chapter 3. Antihistamines: Market Dynamics and Outlook
………….

Chapter 4. Global Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
4.1. Overview
4.2. First Generation Antihistamines
4.2.1. Alimemazine
4.2.2. Chlorphenamine
4.2.3. Clemastine
4.2.4. Cyproheptadine
4.2.5. Hydroxyzine
4.2.6. Ketotifen
4.2.7. Promethazine
4.2.8. Others(Carbinoxamine, Dimenhydrinate, and others)
4.3. Second Generation Antihistamines
4.3.1. Acrivastine
4.3.2. Cetirizine
4.3.3. Desloratadine
4.3.4. Fexofenadine
4.3.5. Levocetirizine
4.3.6. Loratadine
4.4. Pipeline Analysis: Antihistamines Market
4.4.1. Phase III (Forecast till 2026)
4.4.2. Phase II (Tabular Representation)

Chapter 5. Global Antihistamines Market, by Application, 2016–2026 (US$ Mn)
5.1. Overview
5.2. Allergic Rhinitis
5.3. Conjunctivitis
5.4. Urticaria
5.5. Atopic Dermatitis
5.6. Anaphylaxis
5.7. Others (Angioedema, Pruritus, and others)

Chapter 6. Global Antihistamines Market, by Geography, 2016–2026 (US$ Mn)
…………
Chapter 7. Profiles
7.1. Bayer AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Almirall S.A.
7.3. Johnson & Johnson
7.4. AstraZeneca plc
7.5. Novartis AG
7.6. Pfizer, Inc.
7.7. Sanofi SA
7.8. Boehringer Ingelheim GmbH
7.9. Merck & Co., Inc.
7.10. Akorn, Inc.
7.11. Teva Pharmaceutical Industries Ltd.
7.12. Celgene Corporation
7.13. F. Hoffman-La Roche

Browse the full report Antihistamines Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/antihistamines-market

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/antihistamines-market-2018-2026-size-share-and-forecast-credence-research/496073

Source: MarketersMedia

Release ID: 496073